Skip to content Skip to navigation

Buy Cases


Note: By adding the case to cart, you are purchasing the case only.

Displaying 1 - 4 of 4 results

Johnson & Johnson’s Choice of Regional Headquarters and Innovation Hub: Why Singapore?

In 2019, Ai Hua Ong, Group Chairperson, Asia Pacific of Johnson & Johnson (J&J), was ruminating over the choice of Singapore as the company’s regional headquarters (RHQ). While political stability, ease of doing business, a start-up friendly and open innovation ecosystem and supportive...
S$6.00

Artepharm: Commercialising the Malaria Cure in Africa

Discipline:
This case is set January 2019. Song Jianping is senior advisor to Chinese pharmaceutical firm Artepharm, which has been engaging in malaria elimination in Africa since 2003. With a deep understanding of the African market, the company has developed an innovative approach to malaria elimination,...
S$6.00

Rahzi’s Dilemma: Decision-Making at Samudera Pharma Corporation - (A), (B) And (C)

This is a three-part case. Case A introduces Rahzi Putera, a product manager at Samudera Pharma Corporation (SPC), one of Indonesia’s largest manufacturer and distributor of generic pharmaceuticals. SPC had earlier that year entered into an agreement with Braxton Biotech Corporation (Braxton) in...
S$6.00

Novartis Loses Patent Battle In India: Time to Realign the Business Model to Emerging Markets?

On April 1, 2013, the Supreme Court of India rejects Novartis’ patent application for its cancer treatment drug, Glivec. Many share the opinion that Indians should have access to cheaper generic alternatives for life-saving drugs and that multinational pharmaceutical companies should not be allowed...
S$6.00

Looking for something?